Last 12 months
Inside the activity.
1 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 1 | 11 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 11 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC |
Radovich PeterPRESIDENT AND COO
|
Exercise / conversionCommon Stock | 23,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001650131-26-000010 · form4-03172026_070307.xml · nonDerivative · entry 2 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC |
Radovich PeterPRESIDENT AND COO
|
Exercise / conversionCommon Stock | 7,220 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001650131-26-000010 · form4-03172026_070307.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,787 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001614740-26-000009 · form4-03172026_070301.xml · derivative · entry 6 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionPerformance Restricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001614740-26-000009 · form4-03172026_070301.xml · derivative · entry 5 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. F3 · derivative.expiration_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001614740-26-000009 · form4-03172026_070301.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001614740-26-000009 · form4-03172026_070301.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,294 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 20:05 UTC |
Radovich PeterPRESIDENT AND COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 5,912 | $0.00 Strike: $15.87 | $0.00 |
DisclosureSEC source: 0001650131-26-000008 · form4-03112026_080315.xml · derivative · entry 2 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,088 Underlying: Common Stock · 5,912 shares Expires 2032-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| March 06, 2026 Filed Mar 11, 2026 20:05 UTC |
Radovich PeterPRESIDENT AND COO
|
Exercise / conversionCommon Stock | 5,912 | $15.87 | $93,823.44 |
DisclosureSEC source: 0001650131-26-000008 · form4-03112026_080315.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,567 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:38 UTC |
Ramasastry SairaDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $23.51 | $0.00 |
DisclosureSEC source: 0001547959-26-000005 · form4-02172026_090212.xml · derivative · entry 3 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2032-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:38 UTC |
Ramasastry SairaDirector
|
SaleCommon Stock | 2,000 | $102.09 | $204,180.00 |
DisclosureSEC source: 0001547959-26-000005 · form4-02172026_090212.xml · nonDerivative · entry 2 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 18, 2025. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:38 UTC |
Ramasastry SairaDirector
|
Exercise / conversionCommon Stock | 2,000 | $23.51 | $47,020.00 |
DisclosureSEC source: 0001547959-26-000005 · form4-02172026_090212.xml · nonDerivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 02:45 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 968 | $103.30 | $99,997.79 |
DisclosureSEC source: 0001974200-26-000006 · form4-02032026_090202.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,503 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 02:45 UTC |
Radovich PeterPRESIDENT AND COO
|
SaleCommon Stock | 2,631 | $103.30 | $271,791.51 |
DisclosureSEC source: 0001650131-26-000007 · form4-02032026_090206.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,655 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 02:45 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 9,108 | $103.30 | $940,888.28 |
DisclosureSEC source: 0001614740-26-000007 · form4-02032026_090204.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,294 F1 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 02:45 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000006 · form4-02032026_090202.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 02:45 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionCommon Stock | 1,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000006 · form4-02032026_090202.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
GrantPerformance Restricted Stock Units · Derivative | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000004 · form4-01302026_060108.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
GrantRestricted Stock Units · Derivative | 4,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000004 · form4-01302026_060108.xml · derivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,970 Underlying: Common Stock · 4,970 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
GrantStock Option (right to buy) · Derivative | 7,680 | $0.00 Strike: $100.85 | $0.00 |
DisclosureSEC source: 0001974200-26-000004 · form4-01302026_060108.xml · derivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,680 Underlying: Common Stock · 7,680 shares Expires 2036-01-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Quan JoanneCHIEF MEDICAL OFFICER
|
GrantPerformance Restricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001670138-26-000003 · form4-01302026_060106.xml · derivative · entry 3 Quan Joanne · CIK 0001670138 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Quan JoanneCHIEF MEDICAL OFFICER
|
GrantRestricted Stock Units · Derivative | 11,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001670138-26-000003 · form4-01302026_060106.xml · derivative · entry 2 Quan Joanne · CIK 0001670138 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,760 Underlying: Common Stock · 11,760 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Quan JoanneCHIEF MEDICAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 18,140 | $0.00 Strike: $100.85 | $0.00 |
DisclosureSEC source: 0001670138-26-000003 · form4-01302026_060106.xml · derivative · entry 1 Quan Joanne · CIK 0001670138 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,140 Underlying: Common Stock · 18,140 shares Expires 2036-01-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
GrantPerformance Restricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001197350-26-000004 · form4-01302026_060105.xml · derivative · entry 3 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 11,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001197350-26-000004 · form4-01302026_060105.xml · derivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,760 Underlying: Common Stock · 11,760 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 18,140 | $0.00 Strike: $100.85 | $0.00 |
DisclosureSEC source: 0001197350-26-000004 · form4-01302026_060105.xml · derivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,140 Underlying: Common Stock · 18,140 shares Expires 2036-01-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Radovich PeterPRESIDENT AND COO
|
GrantPerformance Restricted Stock Units · Derivative | 34,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001650131-26-000005 · form4-01302026_060103.xml · derivative · entry 3 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,500 Underlying: Common Stock · 34,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Radovich PeterPRESIDENT AND COO
|
GrantRestricted Stock Units · Derivative | 16,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001650131-26-000005 · form4-01302026_060103.xml · derivative · entry 2 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,280 Underlying: Common Stock · 16,280 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Radovich PeterPRESIDENT AND COO
|
GrantStock Option (right to buy) · Derivative | 25,120 | $0.00 Strike: $100.85 | $0.00 |
DisclosureSEC source: 0001650131-26-000005 · form4-01302026_060103.xml · derivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,120 Underlying: Common Stock · 25,120 shares Expires 2036-01-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
GrantPerformance Restricted Stock Units · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001614740-26-000005 · form4-01302026_060101.xml · derivative · entry 3 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 43,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001614740-26-000005 · form4-01302026_060101.xml · derivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,500 Underlying: Common Stock · 43,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (right to buy) · Derivative | 67,000 | $0.00 Strike: $100.85 | $0.00 |
DisclosureSEC source: 0001614740-26-000005 · form4-01302026_060101.xml · derivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,000 Underlying: Common Stock · 67,000 shares Expires 2036-01-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 842 | $96.19 | $80,993.66 |
DisclosureSEC source: 0001974200-26-000002 · form4-01272026_040105.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,700 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,053 | $96.19 | $101,290.18 |
DisclosureSEC source: 0001197350-26-000002 · form4-01272026_040108.xml · nonDerivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,741 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
Radovich PeterPRESIDENT AND COO
|
SaleCommon Stock | 3,143 | $96.19 | $302,331.46 |
DisclosureSEC source: 0001650131-26-000003 · form4-01272026_040106.xml · nonDerivative · entry 2 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,286 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 6,831 | $96.19 | $657,087.55 |
DisclosureSEC source: 0001614740-26-000003 · form4-01272026_040103.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,402 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000002 · form4-01272026_040105.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
Exercise / conversionCommon Stock | 1,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000002 · form4-01272026_040105.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001197350-26-000002 · form4-01272026_040108.xml · derivative · entry 3 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,666 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 2,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001197350-26-000002 · form4-01272026_040108.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
Radovich PeterPRESIDENT AND COO
|
Exercise / conversionRestricted Stock Units · Derivative | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001650131-26-000003 · form4-01272026_040106.xml · derivative · entry 3 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,750 Underlying: Common Stock · 5,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
Radovich PeterPRESIDENT AND COO
|
Exercise / conversionCommon Stock | 5,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001650131-26-000003 · form4-01272026_040106.xml · nonDerivative · entry 1 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001614740-26-000003 · form4-01272026_040103.xml · derivative · entry 4 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001614740-26-000003 · form4-01272026_040103.xml · nonDerivative · entry 1 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:14 UTC |
Heron Patrick JDirector
|
PurchaseCommon Stock | 131,425 | $68.48 | $8,999,984.00 |
DisclosureSEC source: 0001365617-26-000002 · form4-01272026_090122.xml · nonDerivative · entry 2 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Frazier Life Sciences X, L.P. Disclosed balance after: 459,010 F2 · ownership.nature: The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:14 UTC |
Heron Patrick JDirector
|
OtherCommon Stock | 159,277 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001365617-26-000002 · form4-01272026_090122.xml · nonDerivative · entry 1 Heron Patrick J · CIK 0001365617 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Frazier Life Sciences X, L.P. Disclosed balance after: 327,585 F1 · kind: Frazier Life Sciences X, L.P. received these shares in connection with merger of Bluejay Therapeutics, Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's Common Stock was $94.29 per share. F1 · price: Frazier Life Sciences X, L.P. received these shares in connection with merger of Bluejay Therapeutics, Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's Common Stock was $94.29 per share. F2 · ownership.nature: The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 22:30 UTC |
Howe JolandaSVP, GLOBAL CONTROLLER
|
SaleCommon Stock | 926 | $93.33 | $86,419.14 |
DisclosureSEC source: 0001974200-26-000001 · form4-01232026_050110.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,042 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 22:30 UTC |
Quan JoanneCHIEF MEDICAL OFFICER
|
SaleCommon Stock | 1,822 | $93.33 | $170,038.51 |
DisclosureSEC source: 0001670138-26-000002 · form4-01232026_050108.xml · nonDerivative · entry 2 Quan Joanne · CIK 0001670138 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,817 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 22:30 UTC |
BJERKHOLT ERICCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,421 | $93.33 | $132,615.11 |
DisclosureSEC source: 0001197350-26-000001 · form4-01232026_050106.xml · nonDerivative · entry 2 BJERKHOLT ERIC · CIK 0001197350 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,127 F3 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 22:30 UTC |
Radovich PeterPRESIDENT AND COO
|
SaleCommon Stock | 2,382 | $93.33 | $222,300.63 |
DisclosureSEC source: 0001650131-26-000002 · form4-01232026_050104.xml · nonDerivative · entry 2 Radovich Peter · CIK 0001650131 · PRESIDENT AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,679 F3 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 22:30 UTC |
Peetz ChristopherDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 7,098 | $93.33 | $662,422.27 |
DisclosureSEC source: 0001614740-26-000002 · form4-01232026_050101.xml · nonDerivative · entry 2 Peetz Christopher · CIK 0001614740 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,733 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.